Vaccines protect against omicron’s fast-spreading sister variant, BA.2, new data show
By
Alicia Lasek
Feb 01, 2022
COVID-19 vaccines will continue to protect the public against a spinoff omicron gene variant that’s making inroads across the United States, new data from the United Kingdom suggest.
Manageable risks for dementia and heart disease are closely linked, AHA’s annual report finds
By
Alicia Lasek
Jan 27, 2022
There is growing evidence that what is good for the heart is good for the brain. But that knowledge and awareness has not yet trickled down to patients, the authors say.
Environment may play a big role in Alzheimer’s risk, twins study finds
By
Alicia Lasek
Dec 21, 2021
The risk of developing Alzheimer’s-associated brain plaques is only partly due to heredity, a new study of twins finds. The results suggest a role for modifiable factors as well, according to investigators.
Two years into pandemic, we’re better prepared to fight off virus variants
By
Alicia Lasek
Dec 02, 2021
Despite the threat of the quickly spreading and highly mutated omicron coronavirus variant — which has just landed in the U.S. — we are safer than we were before the pandemic, some experts say.
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...
CDC advises COVID boosters for all adults, citing worrisome omicron variant
By
Alicia Lasek
Nov 30, 2021
The new recommendation comes amid rising concerns about the omicron coronavirus variant — yet another reason to get an additional vaccine dose, health officials say.
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.
Clinical briefs for Thursday, Sept. 30
By
Alicia Lasek
Sep 30, 2021
Eli Lilly cuts its generic insulin price by another 40% for Medicare Part D, other beneficiaries … Federal district court judge upholds Ohio provider’s vaccine mandate … $33M awarded to determine...
Donepezil may help preserve muscle cell functioning in Alzheimer’s
By
Alicia Lasek
Sep 28, 2021
People with early Alzheimer’s who are treated with the drug donepezil maintain mitochondrial function in their muscles when compared to their untreated peers, researchers report.